Connections Telix Pharmaceuticals Limited

TLX

AU000000TLX2

Biotechnology & Medical Research

Delayed Australian S.E. Other stock markets 11:06:14 12/05/26 am AEST			5-day change	1st Jan Change
14.58 ^AUD	-2.47%		-5.06%	+30.80%

07/05	Telix Pharmaceuticals Insider Bought Shares Worth $996,738, According to a Recent SEC Filing	MT
05/05	Telix Pharmaceuticals' Investigational Imaging Agent May Potentially Diagnose a Range of Kidney Cancers	MT

9

Listed companies

3

Private companies

39

Insiders

Relation chart of related listed companies: Telix Pharmaceuticals Limited

Active Relations

Past Relations

Related listed companies: Telix Pharmaceuticals Limited

ICON PUBLIC LIMITED COMPANY

Anne Michelle Whitaker

CASTLE BIOSCIENCES, INC.

Tiffany Olson

NUFARM LIMITED

Marie McDonald

PRESCIENT THERAPEUTICS LIMITED

Active Relations

Past Relations

Relationship chart for related private companies: Telix Pharmaceuticals Limited

Active Relations

Past Relations

Related private companies: Telix Pharmaceuticals Limited

Australian Institute of Co. Directors

Miscellaneous Commercial Services

Telix Pharmaceuticals SAS

Biotechnology

Melanie Farris

Douglas Cubbin

Richard Valeix

Advanced Nuclear Medicine Ingredients SA

Wholesale Distributors

Christian Behrenbruch

Melanie Farris

Douglas Cubbin

Richard Valeix

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Medical Specialties	4
Biotechnology	3
Miscellaneous Commercial Services	2
Wholesale Distributors	1
Food: Meat/Fish/Dairy	1
Chemicals: Agricultural	1

Countries of related companies

Australia	7
United States	2
Belgium	1
France	1
Ireland	1

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.

Employees

1,152

Sector

Biotechnology & Medical Research

More about the company